Journal of the American Society of Nephrology (JASN)

Epizode

• Temporal, Cell-Specific Angiopoietin-2 in CKD 18.06.2026 19min

  Dr. Fan-Chi Chang discusses findings from her study, "Cell-Specific Roles of Angiopoietin-2 in CKD," with JASN Deputy Editor Alan S.L. Yu.
• Cardiovascular Effects of GLP-1 RA in Kidney Failure 12.06.2026 28min

  Drs. Benjamin Catanese and Daniel Edmonston discuss their study, "Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure," with JASN Deputy Editor Manjula Kurella Tamura.
• ASN Kidney Translation Series: Artificial Intelligence in Nephrology 09.06.2026 1h 7min

  This ASN Kidney Translation Podcast episode covers advances in artificial intelligence: ASN Workgroup on AI (JASN), AI in nephrology education (CJASN), and ethical issues in AI (K360).
• Subclinical Primary Aldosteronism and eGFR Decline 30.04.2026 30min

  Drs. Gregory Hundemer and Rémi Goupil discuss the results of their study, "Subclinical Primary Aldosteronism and eGFR Decline Over Time," with JASN Deputy Editor David H. Ellison.
• ASN Kidney Translation Series: Peritoneal Dialysis 23.04.2026 1h 19min

  ASN Kidney Translation Podcast episode covers advances in peritoneal dialysis: genetic determinants of ultrafiltration (JASN), fungus-derived ergothioneine depletion in PD (K360), and a survey of PD use in the Veterans Health Administration (CJASN).
• PD Use in Health Service Areas, 2009–2020 31.03.2026 22min

  Dr. Christopher Knapp discusses the findings of his study, "Peritoneal Dialysis Initiation Patterns by Health Service Area during an Era of Expansion," with JASN Deputy Editor Manjula Kurella Tamura.
• ASN Kidney Translation Series: ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure 18.03.2026 22min

  The authors of the ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure discuss optimal approaches to addressing and providing a care path for patients who choose not to pursue dialysis. to support personalized patient care.
• LCN2-Induced CLUH Inhibition Disrupts Mitochondria in Kidney 25.02.2026 26min

  Drs. Morgan Gallazzini and Eloïse Marques discuss the results of their study, "Clustered Mitochondrial Homolog Inhibition by Lipocalin-2 Orchestrates Mitochondrial Disruption and Contributes to Kidney Disease," with JASN Deputy Editor Alan S.L. Yu.
• ASN Kidney Translation Series: Kidney Transplant Advances 09.02.2026 1h 7min

  ASN Kidney Translation Podcast episode covers advances in kidney transplantation: an SGLT2i trial in kidney transplant recipients (CJASN), delivery outcomes after kidney transplantation (JASN), and strategies and policies for living donation (Kidney360).
• Automatic Organ and Cyst Volumes in ADPKD 03.02.2026 27min

  Dr. Martin R. Prince discusses the findings of his study, "Automatically Measuring Kidney, Liver, and Cyst Volumes in Autosomal Dominant Polycystic Kidney Disease," with JASN Deputy Editor David H. Ellison.
• Coronary Disease Screening Prior to Kidney Transplant 08.01.2026 17min

  Dr. Avantika Israni discusses the results of her study, "Class 1 Indications for Coronary Revascularization Identified in Prekidney Transplant Screening" with JASN Deputy Editor Manjula Kurella Tamura and Junior Associate Editor Benjamin Lazarus.
• ASN Kidney Translation Series: Advances in Glomerular Filtration Rate 10.12.2025 1h 6min

  This episode of the ASN Kidney Translation Podcast, hosted by Dr. Matthew Sparks, covers CT-based body composition and GFR estimates in cancer (CJASN), transdermal GFR measurement (JASN), and novel hemodynamic markers in acute heart failure (K360).
• Bone Marrow Inflammation Drives Glomerular Damage 02.12.2025 22min

  Drs. Eunsil Hahm and Ryan Spear discuss the results of their study, "Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble Factors," with JASN Deputy Editor Alan S.L. Yu and Junior Associate Editor Anna Julie Peired.
• ICD Code Accuracy for CVD in CKD 20.11.2025 25min

  Drs. Anna Zemke and Nisha Bansal discuss the findings of their study, "Accuracy of Identification of Cardiovascular Events with International Classification of Diseases Diagnosis Codes versus Physician Adjudication in CKD and Kidney Failure."
• Dapagliflozin and HRQoL in Patients with CKD 11.11.2025 18min

  Dr. Priya Vart discusses the results of his study, "Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKD," with JASN Deputy Editor Manjula Kurella Tamura.
• ASN Kidney Translation Series: Glomerulonephritis 09.10.2025 56min

  In this ASN Kidney Translation podcast episode, we cover a JASN study on podocyte STAT3 deletion in KLF4 podocytopathy, a CJASN report on early C3G recurrence after transplant, and a Kidney360 study linking foot process effacement to disease progression.
• ASN Kidney Translation Series: ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives 18.09.2025 43min

  The authors of the ASN Kidney Health Guidance on Potassium and Phosphorus Food additives discuss clinical approaches to managing hyperkalemia and CKD-mineral and bone disorder risks associated with food additives for people with kidney disease.
• RNA Sequencing of IgA Nephropathy Kidneys 10.09.2025 23min

  Drs. Anna Levin and Annika Wernerson discuss the findings from their study, "Transcriptomic Patterns in Adult and Pediatric Patients with IgA Nephropathy or IgA Vasculitis with Nephropathy," with JASN Deputy Editor David H. Ellison.
• Alternative Splicing and Polyadenylation in Glomerular Disease 04.09.2025 18min

  Drs. Shipra Agrawal and Monoj K. Das discuss the results of their study, "RNA Alternative Splicing and Polyadenylation and Regulation of the Glomerular Filtration Barrier," with JASN Deputy Editor Alan S.L. Yu and Junior Associate Editor Jason O. Wu.
• ASN Kidney Translation Series: Cardiovascular-Kidney Connection 24.07.2025 58min

  Kidney Translation Podcast discusses cardiovascular and kidney disease studies: CKM syndrome stages and mortality prediction, cardiac risk prediction in patients with kidney failure undergoing noncardiac surgery, and SGLT2 inhibition in type 1 diabetes.